APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025177 pages

Choose your research edition.

Industry ResearchHuman Rotavirus Vaccine Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rotavirus Vaccine Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Human Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rotavirus Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rotavirus Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Rotavirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Rotavirus Vaccine include Bharat Biotech, GlaxoSmithKline and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Rotavirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Rotavirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Rotavirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Rotavirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Rotavirus Vaccine Segment by Company

Bharat Biotech

GlaxoSmithKline

Merck

Human Rotavirus Vaccine Segment by Type

Rotarix

RotaTeq

Lanzhou lamb

Rotavin-M1

Rotavac

Others

Human Rotavirus Vaccine Segment by Application

Hospitals & Clinics

Academic And Research

Others

Human Rotavirus Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Rotavirus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Rotavirus Vaccine Industry Trends Table 2. Human Rotavirus Vaccine Industry Drivers Table 3. Human Rotavirus Vaccine Industry Opportunities and Challenges Table 4. Human Rotavirus Vaccine Industry Restraints Table 5. Global Human Rotavirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Rotavirus Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Rotavirus Vaccine Sales Market Share by Manufacturers Table 9. Global Human Rotavirus Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human Rotavirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Rotavirus Vaccine Manufacturers, Product Type & Application Table 13. Global Human Rotavirus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rotarix Table 17. Major Manufacturers of RotaTeq Table 18. Major Manufacturers of Lanzhou lamb Table 19. Major Manufacturers of Rotavin-M1 Table 20. Major Manufacturers of Rotavac Table 21. Major Manufacturers of Others Table 22. Global Human Rotavirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Global Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 25. Global Human Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 26. Global Human Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 27. Global Human Rotavirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Human Rotavirus Vaccine Revenue by Type (2021-2026) & (K Units) Table 29. Global Human Rotavirus Vaccine Revenue by Type (2027-2032) & (K Units) Table 30. Global Human Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 31. Global Human Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospitals & Clinics Table 33. Major Manufacturers of Academic And Research Table 34. Major Manufacturers of Others Table 35. Global Human Rotavirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 37. Global Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 38. Global Human Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 39. Global Human Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 40. Global Human Rotavirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Human Rotavirus Vaccine Revenue by Application (2021-2026) & (K Units) Table 42. Global Human Rotavirus Vaccine Revenue by Application (2027-2032) & (K Units) Table 43. Global Human Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 44. Global Human Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 45. Global Human Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Human Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 47. Global Human Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 48. Global Human Rotavirus Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Human Rotavirus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 52. North America Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Europe Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Europe Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 62. Global Human Rotavirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Human Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Human Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Human Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 66. Global Human Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 67. Bharat Biotech Company Information Table 68. Bharat Biotech Business Overview Table 69. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bharat Biotech Human Rotavirus Vaccine Product Portfolio Table 71. Bharat Biotech Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Human Rotavirus Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Merck Human Rotavirus Vaccine Product Portfolio Table 81. Merck Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Human Rotavirus Vaccine Distributors List Table 85. Human Rotavirus Vaccine Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Human Rotavirus Vaccine Product Image Figure 2. Global Human Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Human Rotavirus Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rotarix Image Figure 9. RotaTeq Image Figure 10. Lanzhou lamb Image Figure 11. Rotavin-M1 Image Figure 12. Rotavac Image Figure 13. Others Image Figure 14. Global Human Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Human Rotavirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 17. Global Human Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Human Rotavirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Human Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 20. Hospitals & Clinics Image Figure 21. Academic And Research Image Figure 22. Others Image Figure 23. Global Human Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Human Rotavirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Human Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 26. Global Human Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Human Rotavirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Human Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 29. North America Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Human Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 31. U.S. Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Human Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 36. Germany Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 43. China Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 51. Brazil Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Human Rotavirus Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Human Rotavirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Human Rotavirus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. North America Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. Europe Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Human Rotavirus Vaccine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Human Rotavirus Vaccine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Rotarix
  • RotaTeq
  • Lanzhou lamb
  • Rotavin-M1
  • Rotavac
  • Others
Applications
  • Hospitals & Clinics
  • Academic And Research
  • Others
Companies covered
  • Bharat Biotech
  • GlaxoSmithKline
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Rotavirus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Rotavirus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Rotavirus Vaccine Market Dynamics
  1. 2.1 Human Rotavirus Vaccine Industry Trends
  2. 2.2 Human Rotavirus Vaccine Industry Drivers
  3. 2.3 Human Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Rotavirus Vaccine Industry Restraints
3 Human Rotavirus Vaccine Market by Manufacturers
  1. 3.1 Global Human Rotavirus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Rotavirus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Rotavirus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Rotavirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Rotavirus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Human Rotavirus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Human Rotavirus Vaccine Market by Type
  1. 4.1 Human Rotavirus Vaccine Type Introduction
  2. 4.1.1 Rotarix
  3. 4.1.2 RotaTeq
  4. 4.1.3 Lanzhou lamb
  5. 4.1.4 Rotavin-M1
  6. 4.1.5 Rotavac
  7. 4.1.6 Others
  8. 4.2 Global Human Rotavirus Vaccine Sales by Type
  9. 4.2.1 Global Human Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Human Rotavirus Vaccine Sales by Type (2021-2032)
  11. 4.2.3 Global Human Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  12. 4.3 Global Human Rotavirus Vaccine Revenue by Type
  13. 4.3.1 Global Human Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Human Rotavirus Vaccine Revenue by Type (2021-2032)
  15. 4.3.3 Global Human Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
5 Human Rotavirus Vaccine Market by Application
  1. 5.1 Human Rotavirus Vaccine Application Introduction
  2. 5.1.1 Hospitals & Clinics
  3. 5.1.2 Academic And Research
  4. 5.1.3 Others
  5. 5.2 Global Human Rotavirus Vaccine Sales by Application
  6. 5.2.1 Global Human Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Rotavirus Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Human Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Rotavirus Vaccine Revenue by Application
  10. 5.3.1 Global Human Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Rotavirus Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Human Rotavirus Vaccine Sales by Region
  1. 6.1 Global Human Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Rotavirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Human Rotavirus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Human Rotavirus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Rotavirus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Rotavirus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Rotavirus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Rotavirus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Rotavirus Vaccine Revenue by Region
  1. 7.1 Global Human Rotavirus Vaccine Revenue by Region
  2. 7.1.1 Global Human Rotavirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Rotavirus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Rotavirus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Rotavirus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Rotavirus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Rotavirus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Rotavirus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Rotavirus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Rotavirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Human Rotavirus Vaccine Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Human Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Human Rotavirus Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Rotavirus Vaccine Value Chain Analysis
  2. 9.1.1 Human Rotavirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Rotavirus Vaccine Production Mode & Process
  6. 9.2 Human Rotavirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Rotavirus Vaccine Distributors
  9. 9.2.3 Human Rotavirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst